Grazia Chiellini
Affiliations: | 1995-2001 | Dipartimento di Patologia Chirurgica, Medica, Molecolare e dell'Area | Università di Pisa, Pisa, Toscana, Italy |
Google:
"Grazia Chiellini"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Saponaro F, Sestito S, Runfola M, et al. (2020) Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders. Frontiers in Medicine. 7: 331 |
| Perra A, Kowalik MA, Cabras L, et al. (2020) Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration. Cell Proliferation. e12808 |
| Rutigliano G, Bandini L, Sestito S, et al. (2020) 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome? International Journal of Molecular Sciences. 21 |
| Bellusci L, Runfola M, Carnicelli V, et al. (2020) Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents Through the Modulation of SIRT6. Molecules (Basel, Switzerland). 25 |
| Runfola M, Sestito S, Bellusci L, et al. (2019) Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis. European Journal of Medicinal Chemistry. 188: 112006 |
| Rogowski M, Bellusci L, Sabatini M, et al. (2019) Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway. International Journal of Molecular Sciences. 20 |
| Laurino A, Landucci E, Cinci L, et al. (2019) Brain Histamine Modulates the Antidepressant-Like Effect of the 3-Iodothyroacetic Acid (TA1). Frontiers in Cellular Neuroscience. 13: 176 |
| Sestito S, Daniele S, Pietrobono D, et al. (2019) Memantine prodrug as a new agent for Alzheimer's Disease. Scientific Reports. 9: 4612 |
| Bellusci L, Laurino A, Sabatini M, et al. (2017) New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection. Frontiers in Pharmacology. 8: 905 |
| Columbano A, Chiellini G, Kowalik MA. (2017) GC-1: a thyromimetic with multiple therapeutic applications in liver disease. Gene Expression |